The Verzenio Market is on a growth trajectory, projected to reach USD 7.8 billion by 2030 with a CAGR of 12.3%. This increase is driven by the rising prevalence of HR-positive, HER2-negative breast cancer, ongoing clinical advancements, and expanding healthcare infrastructure worldwide. North America remains the leading market, but rapid growth is anticipated across the Asia-Pacific region. Ready to uncover the detailed dynamics of the Global Verzenio Market? Get expert insights and strategic analysis today! https://marksparksolutions.com/reports/global-verzenio-abemaciclib-market-trends #VerzenioMarket #AbemaciclibMarketTrends #GlobalVerzenioMarket #BreastCancerTreatment #HealthcareResearch #PharmaceuticalTrends #MarketGrowth #MarkAndSparkSolutions